Wilson Sonsini Advises 858 Therapeutics on IP Matters Related to $50 Million Series B

Retrieved on: 2024-10-01 16:55:39

Tags for this article:

Click the tags to see associated articles and topics

Wilson Sonsini Advises 858 Therapeutics on IP Matters Related to $50 Million Series B. View article details on hiswai:

Excerpt

On September 26, 2024, San Diego-based 858 Therapeutics, a biotechnology and drug discovery company developing a portfolio of small molecule ...

Article found on: www.wsgr.com